ANGPTL3 (human) EIA Kit

ANGPTL3 demonstrates pro-angiogenic effects by binding integrin (alpha)v(beta)3, which induces endothelial cell migration and adhesion. It also dually inhibits the catalytic activities of lipoprotein lipase, which catalyzes the hydrolysis of triglycerides, and endothelial lipase, which hydrolyzes HDL phospholipids. Human ANGPTL3 plasma concentrations positively correlate with plasma HDL cholesterol and HDL phospholipid levels. Cayman's Human ANGPTL3 EIA Kit is an immunometric assay that can be used to measure ANGPTL3 in human serum, plasma, or cell culture supernatants.

Prices direct from Cayman Chemical Company

Quick response times

Exclusive Biosave savings/discounts

SPECIFICATIONS

Catalog Number

580170

Form

1 ea

P Type

Assay Kits

Weight

0

Storage Temp

4

Shipping Temp

4

Additional Info

ANGPTL3 demonstrates pro-angiogenic effects by binding integrin (alpha)v(beta)3, which induces endothelial cell migration and adhesion. It also dually inhibits the catalytic activities of lipoprotein lipase, which catalyzes the hydrolysis of triglycerides, and endothelial lipase, which hydrolyzes HDL phospholipids. In hypolipidemic, yet obese, KK/Snk mice, a reduction in ANGPTL3 expression promotes the clearance of triglycerides, while human ANGPTL3 plasma concentrations positively correlate with plasma HDL cholesterol and HDL phospholipid levels. Cayman's Human ANGPTL3 EIA Kit is an immunometric assay which can be used to measure ANGPTL3 in human serum, plasma, or cell culture supernatants. The assay exhibits a detection limit of 150 pg/ml and an assay range of 0.156-10 ng/ml.